---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-047100"
form_type: "8-K"
ticker: "GRAL"
cik: "0001699031"
company_name: "GRAIL, Inc."
filed_at: "2024-11-12T23:59:59+00:00"
generated_at: "2026-05-30T02:02:07.146608+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# GRAIL Q3 2024: Galleri revenue $25.4M (+52% YoY); net loss $(125.7)M

## Summary
- Total revenue $28.7M (+38% YoY); Galleri revenue $25.4M (+52% YoY).
- Net loss $(125.7)M includes $34.6M amortization and $19.0M restructuring charge.
- Non-GAAP adjusted EBITDA $(108.2)M, improved 14% YoY; adjusted gross profit $11.8M.
- Cash $853.6M, runway into 2028; commercial Galleri tests surpassed 250,000 since launch.
- CEO Bob Ragusa highlighted cost management and progress toward FDA PMA submission.

## SEC filing metadata
- accession: 0001628280-24-047100
- form_type: 8-K
- ticker: GRAL
- cik: 0001699031
- company_name: GRAIL, Inc.
- filed_at: 2024-11-12T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1699031/000162828024047100/0001628280-24-047100-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1699031/000162828024047100/gral-20241112.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-047100
- JSON: https://secwatch.observer/filing/0001628280-24-047100.json
- Plain text: https://secwatch.observer/filing/0001628280-24-047100.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.